ALB and small cell lung carcinoma: In contrast to albumin, elevated dNLR level was associated with an increased risk of death, both in the overall SCLC patient cohort (p=0.003, HR 1.71, 95% CI: 1.20–2.44) and in those with ED-SCLC (p=0.002, HR: 1.91, 95% CI: 1.26–2.91).